Form D · Biotechnology

Kiffik Biomedical, Inc.

Providence, RI · CIK 0001932760

Offering snapshot reported Jun 24, 2022 · SEC filing

Reported sold
$830K
Offering amount: $15M
Investors reported
12
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Sep 22, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$665K$1.33MJun 21, 2022: $1,330,000.00Jun 21, 2022Jun 24, 2022: $830,000.00Jun 24, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,330,000 → $830,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 24, 2022Amendment$830,000-$500,000vs Jun 21, 202212SEC filing
Jun 21, 2022Initial$1,330,000No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-449745

Source: Form D, filed Jun 24, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Cagna Director, Executive, Promoter
Blake Carver Director
Brian Dougan Director, Executive, Promoter
Nicholas Marr Director, Executive, Promoter
Howard Peterson Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
128 Dorrance Street, 6 Th Floor
Providence, RI, 02903